Arbutus Biopharma Corp. (ABUS)
4.235
+0.02
(+0.36%)
USD |
NASDAQ |
Oct 19, 16:00
4.235
0.00 (0.00%)
After-Hours: 16:48
Arbutus Biopharma Cash from Operations (Annual) : -39.64M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -39.64M |
| December 31, 2024 | -64.85M |
| December 31, 2023 | -85.94M |
| December 31, 2022 | -35.36M |
| December 31, 2021 | -67.53M |
| December 31, 2020 | -51.44M |
| December 31, 2019 | -71.01M |
| December 31, 2018 | -67.87M |
| December 31, 2017 | -48.64M |
| December 31, 2016 | -57.88M |
| December 31, 2015 | -54.78M |
| December 31, 2014 | -12.42M |
| December 31, 2013 | -6.739M |
| December 31, 2012 | 33.11M |
| December 31, 2011 | -7.761M |
| Date | Value |
|---|---|
| December 31, 2010 | -10.92M |
| December 31, 2009 | -4.810M |
| December 31, 2008 | -9.676M |
| December 31, 2007 | -2.509M |
| December 31, 2006 | -2.696M |
| December 31, 2005 | -13.97M |
| December 31, 2004 | -9.222M |
| December 31, 2003 | -24.97M |
| December 31, 2002 | -18.20M |
| December 31, 2001 | -10.28M |
| December 31, 2000 | -8.433M |
| December 31, 1999 | -6.665M |
| December 31, 1998 | -7.994M |
| December 31, 1997 | -4.892M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Gossamer Bio, Inc. | -171.27M |
| Legend Biotech Corp. | -100.46M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |